SCTL Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 apr 2024 @ 22:00):

Stats
Dagens volum	512 703
Gjennomsnittsvolum	1.14M
Markedsverdi	116.13M
EPS	$0 ( 2024-03-27 )
Neste inntjeningsdato	( $-0.0300 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.86
ATR14	$0.00200 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Arens Mathew Paul	Sell	19 676 396	Common Stock
2024-04-08	Arens Mathew Paul	Sell	20 000	Stock Option (Right to Buy)
2024-04-08	Arens Mathew Paul	Sell	1 250 000	Pre-Funded Warrant (right to buy)
2024-04-08	Weisman Wayne	Sell	234 982	Common Stock
2024-04-08	Weisman Wayne	Sell	73 620	Common Stock

INSIDER POWER
-39.17
Last 97 transactions
Buy: 17 853 836 \| Sell: 28 337 731

Volum Korrelasjon

Lang: 0.14 (neutral)

Kort: 0.00 (neutral)

Signal:(41.76) Neutral

Societal CDMO, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Societal CDMO, Inc. Korrelasjon - Valuta/Råvare

0.00
( neutral )

-0.09
( neutral )

0.00
( neutral )

-0.10
( neutral )

Societal CDMO, Inc. Økonomi

Annual	2023
Omsetning:	$94.64M
Bruttogevinst:	$18.50M (19.54 %)
EPS:	$-0.140

FY	2023
Omsetning:	$94.64M
Bruttogevinst:	$18.50M (19.54 %)
EPS:	$-0.140

FY	2022
Omsetning:	$90.21M
Bruttogevinst:	$23.14M (25.65 %)
EPS:	$-0.340

FY	2021
Omsetning:	$75.36M
Bruttogevinst:	$19.82M (26.30 %)
EPS:	$-0.479

Financial Reports:

No articles found.

Societal CDMO, Inc.

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.